A potential new federal regulation, proposed in February 2019, would require mammography facilities across the country to include whether a patient has dense breast composition in the report following her screening mammogram.
Dr. Joseph Russo, Section Chief for Mammography at St. Luke's University Health Network, who has tested the training module said, "This online educational tool comes at a critical time when radiologists are seeking more virtual continuing education opportunities. DensityED is an efficient way to improve accuracy and consistency in BI-RADS classification, which is a critical element in increasing the adoption of risk-based screening programs."
Ad Statistics
Times Displayed: 22687
Times Visited: 478 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
DensityED is available to Volpara customers in 39 countries and will be sold independently through DetectED-X. Through this partnership, Volpara will also make BreastED, DetectED-X's gold standard in radiologic breast cancer detection training, available to clinicians. Volpara's density software has been included in more than 300 peer-reviewed articles and research abstracts, and is the most clinically validated automatic, volumetric breast density assessment software in the field of breast cancer research.
About DetectED-X
DetectED-X was founded by a group of Australian-based radiation and imaging experts to help doctors and radiologists worldwide diagnose cases of breast cancer, lung cancer and COVID-19 faster and more accurately. The cloud-based life-saving technology is an educational solution that improves radiological detection rates based on an intelligent interactive educational platform. Detected-X is an award-winning organization that was originally a start-up in the University of Sydney. DetectED-X's vision is to eliminate diagnostic error in imaging globally, particularly in the diagnosis of breast and lung cancer. Medical professionals, hospitals and other institutions can register to gain access to the platform at www.detectedx.com.
About Volpara Health
Volpara Health provides an advanced AI software platform that works with a healthcare provider's expertise to enable a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient's breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. These capabilities are being extended to lung cancer screening. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations including FDA clearance and CE marking and is validated by a volume of peer-reviewed publications unrivaled in the breast screening industry.
SOURCE Volpara Health
Back to HCB News
